Dr. Jan Drappatz, MD
Claim this profileHillman Cancer Center, University of Pittsburgh
Studies Glioblastoma
Studies Lymphoma
7 reported clinical trials
19 drugs studied
Area of expertise
1Glioblastoma
Stage IV
IDH negative
MGMT negative
2Lymphoma
Affiliated Hospitals
Clinical Trials Jan Drappatz, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
Tirabrutinib
for Central Nervous System Lymphoma
This trial is testing tirabrutinib alone and with other cancer drugs in patients with PCNSL. It targets those who haven't responded to previous treatments or are newly diagnosed. Tirabrutinib works by blocking a protein that helps cancer cells grow. Tirabrutinib was approved for use in treating primary central nervous system lymphoma.
Recruiting1 award Phase 210 criteria
More about Jan Drappatz, MD
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Jan Drappatz, MD has experience with
- Temozolomide
- Tirabrutinib
- VAL-083
- VT1021
- Lomustine
- Troriluzole
Breakdown of trials Jan Drappatz, MD has run
Glioblastoma
Central Nervous System Lymphoma
Cholangiocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jan Drappatz, MD specialize in?
Jan Drappatz, MD focuses on Glioblastoma and Lymphoma. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are IDH negative.
Is Jan Drappatz, MD currently recruiting for clinical trials?
Yes, Jan Drappatz, MD is currently recruiting for 5 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Jan Drappatz, MD has studied deeply?
Yes, Jan Drappatz, MD has studied treatments such as Temozolomide, Tirabrutinib, VAL-083.
What is the best way to schedule an appointment with Jan Drappatz, MD?
Apply for one of the trials that Jan Drappatz, MD is conducting.
What is the office address of Jan Drappatz, MD?
The office of Jan Drappatz, MD is located at: Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the Hillman Cancer Center, University of Pittsburgh.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.